C4 Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Due Diligence for Asset Managers
Analyze the public filings of asset managers
Dive into the EDGAR, IAPD, CAFR source data
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
C4 Therapeutics Inc
TickerCCCC
CIK #0001662579
CUSIP12529R107
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address490 Arsenal Way Suite 200, Watertown, MA 02472
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
C4 Therapeutics Inc 2016-01-11 70.3 M Exemption: 506(b) · Remaining: $3,170,000 · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001662579] 10-K
[0001662579] 10-Q
[0001662579] 3
[0001662579] 4
[0001662579] 8-K
[0001662579] D
[0001662579] SC 13D
[0001662579] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Squadron Capital Management LLC C4 Therapeutics Inc [2026-05-19] 0.0
Sirenia Capital Management LP C4 Therapeutics Inc [2026-05-15] 0.0
Bain Capital Life Sciences Fund II LP C4 Therapeutics Inc [2025-10-24] 0.0
RA Capital Management LP C4 Therapeutics Inc [2025-10-24] 0.0
Point72 Asset Management LP C4 Therapeutics Inc [2025-10-20] 0.0
Morgan Stanley C4 Therapeutics Inc [2025-02-03] 0.0
OrbiMed Advisors LLC C4 Therapeutics Inc [2024-11-14] 2.1
BlackRock Inc C4 Therapeutics Inc [2024-11-08] 7.1
BlackRock Inc C4 Therapeutics Inc [2024-10-22] 7.1
State Street Corp C4 Therapeutics Inc [2024-04-10] 10.43
Soleus Capital Master Fund LP C4 Therapeutics Inc [2024-02-05] 5.2
Betta Investment Hong Kong Ltd C4 Therapeutics Inc [2024-01-12] 8.1
Point72 Asset Management LP C4 Therapeutics Inc [2024-01-04] 4.7
RA Capital Management LP C4 Therapeutics Inc [2023-12-26] 9.9
Commodore Capital LP C4 Therapeutics Inc [2023-12-22] 7.7
Lynx1 Capital Management LP C4 Therapeutics Inc [2023-11-13] 6.3
Millennium Management LLC C4 Therapeutics Inc [2023-07-25] 4.8
Soleus Capital Master Fund LP C4 Therapeutics Inc [2023-04-14] 5.0
ArrowMark Colorado Holdings LLC C4 Therapeutics Inc [2023-02-14] 11.85
ArrowMark Colorado Holdings LLC C4 Therapeutics Inc [2022-06-10] 11.09
Price T Rowe Associates Inc /MD/ C4 Therapeutics Inc [2022-02-14] 8.4
RTW Investments LP C4 Therapeutics Inc [2022-02-14] 5.1
BlackRock Inc C4 Therapeutics Inc [2022-02-04] 7.0
Perceptive Advisors LLC C4 Therapeutics Inc [2021-02-16] 7.3
Cobro Ventures Opportunity Fund LP C4 Therapeutics Inc [2020-10-16] 5.8
Cormorant Asset Management LP C4 Therapeutics Inc [2020-10-16] 1.21
Form 3/4/5 Filer 2011 - 2026
C4 Therapeutics Inc
Anderson Kenneth Carl
Grogan Donna Roy
Koppikar Utpal
Hoerter Steven L
Hughes Owen
Bessen Laura
Cooper Ronald Harold Wilfred
Fawell Stephen
Mahaney Paige
Boyle Scott N
Adams Kendra
Hirsch Andrew
Schick Kelly
Mossler Mark
Reyno Leonard
Siegel Jolie
Fisher Stewart
Salter Malcolm
Downey Bruce
Dubin Glenn
White Lauren
Crystal Adam
Cohen Marc A
Cohen Alain J
Prokupets Elena
Wahlberg Laura Jean
McKee William
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Hirsch Andrew
Common Stock
2026-02-15 Option exercise 20,400 $0.00
Hirsch Andrew
Common Stock
2026-02-15 Tax withheld 9,057 $1.89 17,118
Mahaney Paige
Common Stock
2026-02-14 Option exercise 7,050 $0.00
Hirsch Andrew
Common Stock
2026-02-14 Option exercise 81,725 $0.00
Reyno Leonard
Common Stock
2026-02-14 Option exercise 30,950 $0.00
Mahaney Paige
Common Stock
2026-02-14 Tax withheld 2,446 $1.89 4,623
Mossler Mark
Common Stock
2026-02-14 Option exercise 9,420 $0.00
Hirsch Andrew
Common Stock
2026-02-14 Tax withheld 39,154 $1.89 74,001
Boyle Scott N
Common Stock
2026-02-14 Option exercise 20,950 $0.00
Boyle Scott N
Common Stock
2026-02-14 Tax withheld 7,269 $1.89 13,738
Mossler Mark
Common Stock
2026-02-14 Tax withheld 3,268 $1.89 6,177
Schick Kelly
Common Stock
2026-02-14 Option exercise 20,950 $0.00
Schick Kelly
Common Stock
2026-02-14 Tax withheld 7,269 $1.89 13,738
Adams Kendra
Common Stock
2026-02-14 Option exercise 30,950 $0.00
Adams Kendra
Common Stock
2026-02-14 Tax withheld 15,381 $1.89 29,070
Reyno Leonard
Common Stock
2026-02-14 Tax withheld 16,579 $1.89 31,334
Boyle Scott N
Common Stock
2026-02-13 Grant 200,000 $0.00
Mossler Mark
Common Stock
2026-02-13 Grant 56,980 $0.00
Schick Kelly
Common Stock
2026-02-13 Grant 200,000 $0.00
Adams Kendra
Common Stock
2026-02-13 Tax withheld 1,863 $1.89 3,521
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 123 83,178,179
2025-12-31 101 80,044,857
2025-09-30 99 53,058,767
2025-06-30 101 54,928,210
2025-03-31 115 64,136,862
2024-12-31 117 65,166,084
2024-09-30 122 64,820,582
2024-06-30 116 61,347,361
2024-03-31 107 57,917,892
2023-12-31 93 45,840,799
2023-09-30 85 34,695,814
2023-06-30 101 31,443,323
Form 13F Holdings
Firm Period DFND Voting Shares
Wasatch Advisors LP [2026-06-30] SOLE 3,522,644 3,522,644
Congress Asset Management Co [2026-06-30] SOLE 864,137 1,003,437
[2026-06-30] SOLE 0 14,129
Owl Creek Wealth Partners LLC [2026-06-30] SOLE 0 2,140
Fortitude Family Office LLC [2026-06-30] SOLE 435 435
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com